newsfilter
← Latest News
PR Newswire·

Mirati Therapeutics Announces Departure of Chief Executive Officer David Meek

Charles M. Baum, M.D., Ph.D. assumes role of interim CEO SAN DIEGO, Aug. 8, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ:MRTX), a commercial stage biotechnology company today announced that David Meek